Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02060370
Title Sunitinib Scheduling in Metastatic Renal Cell Carcinoma (mRCC)
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

clear cell renal cell carcinoma

Therapies

Sunitinib

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Stanford University Medical Center Stanford California 94305 United States Details
Lineberger Cancer Center Chapel Hill North Carolina 27514 United States Details
Cleveland Clinic Taussig Cancer Institute Cleveland Ohio 44195 United States Details
Fox Chase Cancer Center Philadelphia Pennsylvania 19111-2497 United States Details
University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field